Now the new €130 million, 19,000m2 manufacturing facility near Amsterdam is able to support delivery of up to 4,000 cell therapies each year for eligible cancer patients across Europe. But backtrack to August 2018 and the very first European patients were also receiving treatment, part of an...
1). Some companies are experts in the search of compounds for in-licensing; some focus on marketing specialty medicines to a limited number of clients; some started as a generic company; and some with a specific delivery technology knowhow. The world largest generic company, Teva (“Nature”...
In one embodiment of the present invention, in the region existing in the GRCh38.p12 position of human chromosome 19 (Chr19), region near the transcription start point of the DMPK gene: 45,777,342-45,784,715 can be the expression regulatory region of human DMPK gene. As shown in the E...
company culture, and most importantly, the relative sustainability of the contracts associated with the acquisition of each unit. It would prove the best strategy to turn the company around would be to focus on each site’s unique pluses and minuses, and determine which s...
Data were recorded by PHERAstar Plus, Data acquisition and analysis were performed using Microsoft Excel program and GraphPad Prism v.6 software.TABLE 9 Growth inhibition assay of Hep3B-Luc cell line in presence of compound 2-3 Compounds Doxorubicin 2-3 Cell lines BEL-7402 Hep3B-Luc EC50 (...
“More than just a factory, (Modulus) redefines healthcare delivery with flexibility and speed, enabling us to meet the changing needs of the pipeline across multiple modalities, as well as respond with urgency to future public health challenges," Brendan O’Callaghan, Sanofi’s VP of manufacturi...
Digital health interventions refer to the use of digital technology and connected devices to improve health outcomes and healthcare delivery. This includes telemedicine, electronic health records, wearable devices, mobile health applications, and other forms of digital health technology. To this end, sev...
Colombo S (2020) Chapter 4—Applications of artificial intelligence in drug delivery and pharmaceutical development. In: Bohr A, Memarzadeh K (eds) Artificial intelligence in healthcare. Academic Press, Cambridge, Massachusetts, pp 85–116. https://doi.org/10.1016/B978-0-12-818438-7.00004-6 ...
Demidova-Rice, Tatiana N., PhD et al., Acute and Impaired Wound Healing: Pathophysiology and Current Methods for Drug Delivery, Part 2: Role of Growth Factors in Normal and Pathological Wound Healing: Therapeutic Potential and Methods of Delivery, Advances in Skin and Wound Care, 2012, 25(8...